Regulation of Vascular Reactivity in Scleroderma: New Insights into Raynaud’s Phenomenon
-
2008/02/01
-
By Flavahan NA
Details
-
Personal Author:
-
Description:Because of the role of the RhoA/Rho kinase (ROCK) pathway in regulating numerous pathologic processes including vasoconstriction, vascular remodeling, and fibrosis, ROCK inhibitors may be especially beneficial in treating Raynaud's phenomenon and scleroderma. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:0889-857X
-
Document Type:
-
Funding:
-
Genre:
-
Place as Subject:
-
CIO:
-
Topic:
-
Location:
-
Pages in Document:81-87
-
Volume:34
-
Issue:1
-
NIOSHTIC Number:nn:20033860
-
Citation:Rheum Dis Clin North Am 2008 Feb; 34(1):81-87
-
Contact Point Address:Nicholas A. Flavahan PhD, Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University, Ross Research Building R370, 720 Rutland Avenue, Baltimore, MD 21205
-
Email:nflavah1@jhmi.edu
-
Federal Fiscal Year:2008
-
Performing Organization:Jonhs Hopkins University
-
Peer Reviewed:True
-
Start Date:20050801
-
Source Full Name:Rheumatic Diseases Clinics of North America
-
End Date:20100731
-
Collection(s):
-
Main Document Checksum:urn:sha-512:db33dbe5f847149db176d5e3fcbc48f5a16541fc7f6b8c004630b7abb99fa6f93c08b7c0bd4591de8072309166a3d6e513c08e853d0d8e6911a0f3af84cc0567
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like